Access to high quality data and a clear strategy to derive valuable insights from that data is no longer seen as a ‘nice to have’ but is recognized as a ‘must have’ in the pharmaceutical industry.
But the pressures of Covid, coupled with increasing and highly sensitive concerns around data privacy and ever tightening regulation presents a significant obstacle. While the pandemic has vastly accelerated digital transformation across industries, the Pharma Commercial model is still working to catchup. While many companies have made significant investments in CMS, CRM and Martech platforms, most are only able to extract a fraction of the value out of these investments. Fewer still are able to put these insights into play to drive results.
How can we adjust to an environment where HCP access is increasingly limited? What does this mean for the Pharma Commercial model moving forward? And how can the Pharmaceutical industry leverage first party data to personalise communications?
Join Merge Inc and a select group of leading industry peers in this virtual round table from Meet The Boss, as we discuss bringing digital transformation to the Pharma Commercial Model.